OVID logo

Ovid Therapeutics (OVID) Cash From Financing

Annual CFF

$30.54 M
+$30.35 M+16798.28%

December 31, 2023

Summary

Performance

1-Year Change

+16798.28%

3-Year Change

-35.13%

5-Year Change

+10572.91%

15-Year Change

-54.22%

OVID Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

73.08%
OVID annual cash flow from financing activities is higher than 73.08% of companies in Healthcare sector

High & Low

All-time High

$86.54 M
OVID annual cash flow from financing activities is currently -64.72% below its historical high of $86.54 million

3-Year Low

$180.70 K
OVID annual cash flow from financing activities is currently >+9900.00% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
OVID previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 7, 2025
OVID next annual earnings announcement is scheduled for Mar 7, 2025

OtherOVIDcash flowmetrics:

Annual CFI

-$2.58 M
OVID annual cash flow from investing activities is -$2.58 million

Annual CFO

-$45.78 M
OVID annual cash flow from operations is -$45.78 million

Annual FCF

-$45.92 M
OVID annual free cash flow is -$45.92 million

Annual CAPEX

$137.50 K
OVID annual capital expenditures is $137.50 thousand

Quarterly CFF

$38.00 K
-$318.00 K-89.33%

September 30, 2024

Summary

Performance

3-Month Change

-89.33%

1-Year Change

-99.87%

3-Year Change

-99.87%

5-Year Change

-99.87%

OVID Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

49.61%
OVID quarterly cash flow from financing activities is higher than 49.61% of companies in Healthcare sector

High & Low

All-time High

$67.91 M
OVID quarterly cash flow from financing activities is currently -99.94% below its historical high of $67.91 million

3-Year Low

-$43.60 K

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
OVID previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 7, 2025
OVID next earnings announcement is scheduled for Mar 7, 2025

OtherOVIDcash flowmetrics:

Quarterly CFI

$292.00 K
OVID quarterly cash flow from investing activities is $292.00 thousand

Quarterly CFO

-$15.01 M
OVID quarterly cash flow from operations is -$15.01 million

Quarterly FCF

-$15.00 M
OVID quarterly free cash flow is -$15.00 million

Quarterly CAPEX

-$4000.00
OVID quarterly capital expenditures is -$4000.00

TTM CFF

$30.66 M
-$186.00 K-0.60%

September 30, 2024

Summary

Performance

3-Month Change

-0.6%

1-Year Change

+0.39%

3-Year Change

+0.39%

5-Year Change

+0.39%

OVID TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

69.28%
OVID TTM cash flow from financing activities is higher than 69.28% of companies in Healthcare sector

High & Low

All-time High

$103.19 M
OVID TTM cash flow from financing activities is currently -70.29% below its historical high of $103.19 million

3-Year Low

$180.60 K
OVID TTM cash flow from financing activities is currently >+9900.00% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
OVID previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 7, 2025
OVID next earnings announcement is scheduled for Mar 7, 2025

OtherOVIDcash flowmetrics:

TTM CFI

-$15.21 M
OVID TTM cash flow from investing activities is -$15.21 million

TTM CFO

-$57.86 M
OVID TTM cash flow from operations is -$57.86 million

TTM FCF

-$58.02 M
OVID TTM free cash flow is -$58.02 million

TTM CAPEX

$165.50 K
OVID TTM capital expenditures is $165.50 thousand

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

OVID Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+10000.0%-99.9%+0.4%
3 y3 years-35.1%-99.9%+0.4%
5 y5 years+10000.0%-99.9%+0.4%

OVID Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high>+9999.0%-99.9%+187.2%-0.6%>+9999.0%
5 y5-year-64.7%>+9999.0%-99.9%+116.3%-70.3%>+9999.0%
alltimeall time-64.7%>+9999.0%-99.9%+105.2%-70.3%+5943.5%

Ovid Therapeutics Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2024
-
$38.00 K(-89.3%)
$30.66 M(-0.6%)
Jun 2024
-
$356.00 K(+56.1%)
$30.84 M(+0.5%)
Mar 2024
-
$228.00 K(-99.2%)
$30.70 M(+0.5%)
Dec 2023
$30.54 M(>+9900.0%)
$30.03 M(>+9900.0%)
$30.54 M(+6561.3%)
Sep 2023
-
$224.00 K(+6.2%)
$458.40 K(+45.1%)
Jun 2023
-
$211.00 K(+214.9%)
$316.00 K(+47.3%)
Mar 2023
-
$67.00 K(-253.7%)
$214.50 K(+18.8%)
Dec 2022
$180.70 K(-80.0%)
-$43.60 K(-153.4%)
$180.60 K(-45.8%)
Sep 2022
-
$81.60 K(-25.5%)
$333.40 K(-58.4%)
Jun 2022
-
$109.50 K(+230.8%)
$800.90 K(-0.8%)
Mar 2022
-
$33.10 K(-69.7%)
$807.60 K(-10.7%)
Dec 2021
$904.10 K(-98.1%)
$109.20 K(-80.1%)
$904.20 K(+60.7%)
Sep 2021
-
$549.10 K(+372.5%)
$562.50 K(-98.8%)
Jun 2021
-
$116.20 K(-10.4%)
$47.13 M(-0.1%)
Mar 2021
-
$129.70 K(-155.8%)
$47.19 M(+0.2%)
Dec 2020
$47.07 M
-$232.50 K(-100.5%)
$47.07 M(-54.4%)
Sep 2020
-
$47.12 M(>+9900.0%)
$103.19 M(+83.8%)
Jun 2020
-
$169.30 K(+992.3%)
$56.13 M(+1.0%)
DateAnnualQuarterlyTTM
Mar 2020
-
$15.50 K(-100.0%)
$55.57 M(-35.8%)
Dec 2019
$86.54 M(>+9900.0%)
$55.89 M(>+9900.0%)
$86.54 M(+182.3%)
Sep 2019
-
$58.80 K(-115.0%)
$30.65 M(-0.2%)
Jun 2019
-
-$391.90 K(-101.3%)
$30.71 M(-1.6%)
Mar 2019
-
$30.99 M(>+9900.0%)
$31.20 M(>+9900.0%)
Dec 2018
$286.10 K(-99.6%)
$0.00(-100.0%)
$286.10 K(-8.6%)
Sep 2018
-
$112.00 K(+13.5%)
$313.10 K(-159.7%)
Jun 2018
-
$98.70 K(+30.9%)
-$524.60 K(-100.8%)
Mar 2018
-
$75.40 K(+179.3%)
$67.28 M(+0.9%)
Dec 2017
$66.70 M(<-9900.0%)
$27.00 K(-103.7%)
$66.70 M(+0.1%)
Sep 2017
-
-$725.70 K(-101.1%)
$66.66 M(-1.1%)
Jun 2017
-
$67.91 M(<-9900.0%)
$67.39 M(<-9900.0%)
Mar 2017
-
-$505.20 K(+3587.6%)
-$482.60 K(+3422.6%)
Dec 2016
-$13.70 K(-100.0%)
-$13.70 K(<-9900.0%)
-$13.70 K(<-9900.0%)
Sep 2016
-
$0.00(-100.0%)
$0.00(0.0%)
Jun 2016
-
$36.30 K(-200.0%)
$0.00(-100.0%)
Mar 2016
-
-$36.30 K
-$36.30 K
Dec 2015
$70.64 M
-
-

FAQ

  • What is Ovid Therapeutics annual cash flow from financing activities?
  • What is the all time high annual CFF for Ovid Therapeutics?
  • What is Ovid Therapeutics annual CFF year-on-year change?
  • What is Ovid Therapeutics quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Ovid Therapeutics?
  • What is Ovid Therapeutics quarterly CFF year-on-year change?
  • What is Ovid Therapeutics TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Ovid Therapeutics?
  • What is Ovid Therapeutics TTM CFF year-on-year change?

What is Ovid Therapeutics annual cash flow from financing activities?

The current annual CFF of OVID is $30.54 M

What is the all time high annual CFF for Ovid Therapeutics?

Ovid Therapeutics all-time high annual cash flow from financing activities is $86.54 M

What is Ovid Therapeutics annual CFF year-on-year change?

Over the past year, OVID annual cash flow from financing activities has changed by +$30.35 M (+16798.28%)

What is Ovid Therapeutics quarterly cash flow from financing activities?

The current quarterly CFF of OVID is $38.00 K

What is the all time high quarterly CFF for Ovid Therapeutics?

Ovid Therapeutics all-time high quarterly cash flow from financing activities is $67.91 M

What is Ovid Therapeutics quarterly CFF year-on-year change?

Over the past year, OVID quarterly cash flow from financing activities has changed by -$30.00 M (-99.87%)

What is Ovid Therapeutics TTM cash flow from financing activities?

The current TTM CFF of OVID is $30.66 M

What is the all time high TTM CFF for Ovid Therapeutics?

Ovid Therapeutics all-time high TTM cash flow from financing activities is $103.19 M

What is Ovid Therapeutics TTM CFF year-on-year change?

Over the past year, OVID TTM cash flow from financing activities has changed by +$120.00 K (+0.39%)